(Q43930022)

28 November 2017

title

IL-6 as a biomarker of ischemic cerebrovascular disease (English)

1 reference

28 November 2017

0 references

Vanessa P Moreno

1

1 reference

28 November 2017

Dolores Subirá

series ordinal

2

1 reference

28 November 2017

Elena Meseguer

series ordinal

3

1 reference

28 November 2017

Pilar Llamas

series ordinal

4

1 reference

28 November 2017

publication date

1 April 2008

1 reference

28 November 2017

published in

Biomarkers in Medicine

1 reference

28 November 2017

volume

2

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

125-136

1 reference

Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Genetic risk for ischemic and hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Why now? Moving from stroke risk factors to stroke triggers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammatory response after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Multiple levels of regulation of the interleukin-6 system in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

21 January 2018

The genetics of stroke

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammatory mechanisms after ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammation and infections as risk factors for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Modulation of the inflammatory response in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Role of inflammation in stroke and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammatory Reactions in the Pathogenesis of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammation in atherosclerosis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Intrathecal release of pro- and anti-inflammatory cytokines during stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammatory markers and in-hospital mortality in acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Molecular insights on the cerebral innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Immune function of astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Chronic interleukin-6 alters the level of synaptic proteins in hippocampus in culture and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Systemic complement activation following human acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

IL-6: an early marker for outcome in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Inflammatory biomarkers in blood of patients with acute brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Neuroprotection and neurosupplementation in ischaemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.2.125

21 January 2018

Identifiers

DOI

10.2217/17520363.2.2.125

1 reference

28 November 2017

1 reference